Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
7333 Mississauga Road, , ON, L5N 6L4, CA
Bora Pharmaceuticals is a full-service global CDMO specializing in the development and manufacturing of complex oral solid, liquid, semi-solid, ophthalmic, biologics, and sterile injectable pharmaceutical products for clinical and commercial use. Our comprehensive solutions and high-end global capacity enable our clients to deliver much-needed therapeutics to patients worldwide.
Explore how delivering therapeutic compounds and molecules via spheronized forms will support your most challenging drug product manufacturing goals.
Released By Bora Pharmaceuticals
Bora’s Technology Transfer Whitepaper will help you discover key strategies to successfully transfer and scale Rx & OTC drugs.
Multiple-unit pellet system (MUPS) can offer a solution to complex dose control
Synchronizing and controlling API delivery, E-S offers pharmaceutical companies a robust technique to manufacture today’s most complex therapeutics.
Expands its production capabilities and enables larger volumes at higher speeds with greater flexibility, particularly for dermatologic products.
By: Charlie Sternberg
Will add further sterile fill/finish capacity over the course of the next year.
Agnus joins Bora Group from KBI Biopharma, where he led global business development.
J.D. Mowery brings nearly 25 years of experience in the CDMO and biopharmaceutical industries.
Will combine their biomanufacturing facilities to create a global service for biologics development and supply.
By: Kristin Brooks
The newly acquired facility provides drug product manufacturing services for sterile injectables.
Creates an independent global specialist CRO in fast-growing markets.
Through this acquisition Merck will add Ohtuvayre to its growing cardio-pulmonary pipeline and portfolio.
Strengthens Ofichem’s integrated development offering, enabling it to offer broader, deeper support from early-phase development through to GMP production.
Expands its capacity for assembly and packaging for the pharmaceutical sector.
Strengthens BioMarin's enzyme therapies portfolio, adding a late-stage enzyme replacement therapy, INZ-701.
Forms a rare tumor business for Merck KGaA, Darmstadt, Germany, including SpringWorks’ portfolio and pimicotinib.
Strengthens its global particle engineering capabilities.
Mark Foster, General Manager of Oliver Design, shares insights on balancing patient needs, manufacturability, and sustainability in biopharma packaging.
Enhances its capabilities across development, manufacturing, and global distribution of commercial and clinical therapeutic radiopharmaceuticals.
The all-stock transaction will build on BioNTech’s proven track record and established position in the global mRNA industry.
Will support the global expansion of Eutecma’s sustainable, modular, and reusable cold chain packaging solutions.
Vice President of Quality and Regulatory discusses the industry's expectations of CDMOs in today’s market and advancing to support evolving needs.
Released By Grand River Aseptic Manufacturing
Agrees to acquire two biologics manufacturing facilities from Agenus Inc. in California.
Addressing increasing complexity, cost of drug development, and navigating regulatory compliance.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
